Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VKTX
VKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest VKTX ETF News Today | Earnings, Events & Price Alerts
VKTX News
Viking Therapeutics: A Major Player in the Weight Loss Arena
4d ago
Marketbeat
Eli Lilly Strengthens Lead in Weight Loss Drug Market
5d ago
Fool
Eli Lilly's Dominance in the GLP-1 Market
5d ago
NASDAQ.COM
Investment Opportunities in the Weight Loss Drug Market
Feb 24 2026
Fool
Viking Therapeutics Shows Strong Mid-Stage Data for VK2735
Feb 24 2026
NASDAQ.COM
Viking Therapeutics Could Be a Weight-Loss Drug Moon Shot
Feb 24 2026
Yahoo Finance
Novo Nordisk Stock Hits 52-Week Low After Trial Failure
Feb 23 2026
Benzinga
Novo Nordisk's Weight-Loss Drug Fails in Trials, Boosts Viking Therapeutics
Feb 23 2026
NASDAQ.COM
Wall Street Opens Under Pressure Amid AI Credit Concerns
Feb 23 2026
Benzinga
Viking Therapeutics Shares Surge on Competitor News
Feb 23 2026
Fool
Eli Lilly's Dominance in Obesity Drug Market Reinforced
Feb 23 2026
CNBC
Viking Therapeutics Poised for Growth in Weight Loss Drug Market
Feb 23 2026
Fool
Biotech Stocks with High Growth Potential
Feb 20 2026
Fool
Viking Therapeutics Stock Price Potential Analysis
Feb 19 2026
Fool
Viking Therapeutics Nears Completion of GLP-1 Weight Loss Drug Development
Feb 19 2026
NASDAQ.COM
Viking Therapeutics Targets Weight Loss Drug Market Growth
Feb 17 2026
Fool
Show More News
